Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-28 @ 12:06 AM
Study NCT ID:
NCT00005634
Status:
COMPLETED
Last Update Posted:
2013-06-19
First Post:
2000-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-01
Start Date Type:
None
Primary Completion Date:
2002-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-10
Completion Date Type:
ACTUAL
First Submit Date:
2000-05-02
First Submit QC Date:
None
Study First Post Date:
2003-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-18
Last Update Post Date:
2013-06-19
Last Update Post Date Type:
ESTIMATED